Literature DB >> 27702963

Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy.

Andrew W Roberts1, Joel F Farley2, G Mark Holmes3, Christine U Oramasionwu4, Chris Ringwalt5, Betsy Sleath6, Asheley C Skinner7.   

Abstract

Controlled substance lock-in programs are garnering increased attention from payers and policy makers seeking to combat the epidemic of opioid misuse. These programs require high-risk patients to visit a single prescriber and pharmacy for coverage of controlled substance medication services. Despite high prevalence of the programs in Medicaid, we know little about their effects on patients' behavior and outcomes aside from reducing controlled substance-related claims. Our study was the first rigorous investigation of lock-in programs' effects on out-of-pocket controlled substance prescription fills, which circumvent the programs' restrictions and mitigate their potential public health benefits. We linked claims data and prescription drug monitoring program data for the period 2009-12 for 1,647 enrollees in North Carolina Medicaid's lock-in program and found that enrollment was associated with a roughly fourfold increase in the likelihood and frequency of out-of-pocket controlled substance prescription fills. This finding illuminates weaknesses of lock-in programs and highlights the need for further scrutiny of the appropriate role, optimal design, and potential unintended consequences of the programs as tools to prevent opioid abuse. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Lock-in program; Medicaid; Opioids; Pharmaceutical policy; Prescription drug abuse

Mesh:

Substances:

Year:  2016        PMID: 27702963      PMCID: PMC7262687          DOI: 10.1377/hlthaff.2016.0355

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  15 in total

1.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.

Authors:  Matthew Daubresse; Hsien-Yen Chang; Yuping Yu; Shilpa Viswanathan; Nilay D Shah; Randall S Stafford; Stefan P Kruszewski; G Caleb Alexander
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

2.  Pharmacy lock-in program promotes appropriate use of resources.

Authors:  Lynn Mitchell
Journal:  J Okla State Med Assoc       Date:  2009-08

Review 3.  Assessing the present state and potential of Medicaid controlled substance lock-in programs.

Authors:  Andrew W Roberts; Asheley Cockrell Skinner
Journal:  J Manag Care Spec Pharm       Date:  2014-05

4.  Trends in opioid analgesic abuse and mortality in the United States.

Authors:  Richard C Dart; Hilary L Surratt; Theodore J Cicero; Mark W Parrino; S Geoff Severtson; Becki Bucher-Bartelson; Jody L Green
Journal:  N Engl J Med       Date:  2015-01-15       Impact factor: 91.245

5.  Pharmaceutical overdose deaths, United States, 2010.

Authors:  Christopher M Jones; Karin A Mack; Leonard J Paulozzi
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

6.  Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013.

Authors:  Beth Han; Wilson M Compton; Christopher M Jones; Rong Cai
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

7.  Economic costs of nonmedical use of prescription opioids.

Authors:  Ryan N Hansen; Gerry Oster; John Edelsberg; George E Woody; Sean D Sullivan
Journal:  Clin J Pain       Date:  2011 Mar-Apr       Impact factor: 3.442

8.  North Carolina Medicaid recipient management lock-in program: the pharmacist's perspective.

Authors:  S Rose Werth; Nidhi Sachdeva; Andrew W Roberts; Mariana Garrettson; Chris Ringwalt; Leslie A Moss; Theodore Pikoulas; Asheley Cockrell Skinner
Journal:  J Manag Care Spec Pharm       Date:  2014-11

9.  Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States.

Authors:  Carl L Roland; Ashish V Joshi; Jack Mardekian; Steven C Walden; James Harnett
Journal:  J Opioid Manag       Date:  2013 May-Jun

10.  Patient Outcomes in a Medicaid Managed Care Lock-In Program.

Authors:  Theresa R F Dreyer; Thomas Michalski; Brent C Williams
Journal:  J Manag Care Spec Pharm       Date:  2015-11
View more
  8 in total

1.  Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.

Authors:  Rebecca B Naumann; Andrew W Roberts; Stephen W Marshall; Asheley C Skinner
Journal:  Med Care       Date:  2019-03       Impact factor: 2.983

2.  The lock-in loophole: Using mixed methods to explain patient circumvention of a Medicaid opioid restriction program.

Authors:  Andrew W Roberts; Asheley C Skinner; Julie C Lauffenburger; Kimberly A Galt
Journal:  Subst Abus       Date:  2019-10-23       Impact factor: 3.716

3.  Medicaid prior authorization and opioid medication abuse and overdose.

Authors:  Gerald Cochran; Adam J Gordon; Walid F Gellad; Chung-Chou H Chang; Wei-Hsuan Lo-Ciganic; Carroline Lobo; Evan Cole; Winfred Frazier; Ping Zheng; David Kelley; Julie M Donohue
Journal:  Am J Manag Care       Date:  2017-05-01       Impact factor: 2.229

4.  Health Care Utilization and Comorbidity History of North Carolina Medicaid Beneficiaries in a Controlled Substance "Lock-in" Program.

Authors:  Rebecca B Naumann; Stephen W Marshall; Jennifer L Lund; Asheley C Skinner; Christopher Ringwalt; Nisha C Gottfredson
Journal:  N C Med J       Date:  2019 May-Jun

5.  Exploration of the STOP Act and Opioid Deaths in North Carolina, 2010-2018.

Authors:  Phillip Hughes; Sheri Denslow; Bayla Ostrach; Carriedelle Fusco; Casey Tak
Journal:  Am J Public Health       Date:  2020-08-20       Impact factor: 11.561

Review 6.  The state of the science in opioid policy research.

Authors:  Megan S Schuler; Sara E Heins; Rosanna Smart; Beth Ann Griffin; David Powell; Elizabeth A Stuart; Bryce Pardo; Sierra Smucker; Stephen W Patrick; Rosalie Liccardo Pacula; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2020-06-27       Impact factor: 4.492

7.  A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.

Authors:  Sanae El Ibrahimi; Sara Hallvik; Kirbee Johnston; Gillian Leichtling; Esther Choo; Daniel M Hartung
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-08-10       Impact factor: 2.732

8.  Evidence for state, community and systems-level prevention strategies to address the opioid crisis.

Authors:  Tamara M Haegerich; Christopher M Jones; Pierre-Olivier Cote; Amber Robinson; Lindsey Ross
Journal:  Drug Alcohol Depend       Date:  2019-09-19       Impact factor: 4.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.